Cefuroxime And Dextrose Injection, Solution
Product Images NDC 0264-3114

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Cefuroxime And Dextrose (NDC 0264-3114). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by B. Braun Medical Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Cefuroxime For Injection Usp And Dextrose Injectio 1)

Chemical structure of the active ingredient cefuroxime as depicted in the image, showing its molecular configuration including functional groups and ring systems.*

FDA Label Image

3114-11 Container Label (Cefuroxime For Injection Usp And Dextrose Injectio 10)

Label for Cefuroxime and Dextrose Injection USP 1.5 g per 50 mL solution in a duplex container. The label indicates it is for intravenous use, single dose, sterile and nonpyrogenic. It includes instructions for reconstitution, storage, and use, and states it is not made with natural rubber latex, PVC, or DEHP. The label shows the manufacturer as B. Braun Medical Inc., Bethlehem, PA, with lot, expiration, and NDC barcode details.*

FDA Label Image

Drug Chamber Label (Cefuroxime For Injection Usp And Dextrose Injectio 11)

This is a drug chamber label panel instructing to discard the unit if the foil strip is damaged, peel the foil strip only when ready for use, and visually inspect the drug prior to reconstitution. It also advises to see the package insert for complete directions for reconstitution and administration.*

FDA Label Image

Chemical Structure (Cefuroxime For Injection Usp And Dextrose Injectio 2)

Chemical structure diagram of the active ingredient dextrose, showing its molecular formula fragments and hydroxyl groups.*

FDA Label Image

Diagram 1 (Cefuroxime For Injection Usp And Dextrose Injectio 3)

An instructional diagram labeled 'Diagram 1' showing how to use the side tab on a packaging or device, with an arrow indicating the direction to pull or open it.*

FDA Label Image

Diagram 2 (Cefuroxime For Injection Usp And Dextrose Injectio 4)

An instructional diagram showing the parts of a dual-chamber injection system. It labels the hanger tab, diluent chamber, foil strip with a 'Peel Here' indication, drug powder chamber, and set port with foil cover. The diagram illustrates the separation of diluent and drug powder in a single injection device.*

FDA Label Image

Diagram 3 (Cefuroxime For Injection Usp And Dextrose Injectio 5)

An instructional diagram showing hands manipulating a component of an intravenous injection solution container. The illustration highlights a step in handling or preparing the injection device, labeled as Diagram 3.*

FDA Label Image

Diagram 4 (Cefuroxime For Injection Usp And Dextrose Injectio 6)

An instructional diagram showing hands holding a component of an intravenous injection system. The image depicts a step involving the attachment or removal of a part, indicated by an arrow pointing downward toward a connector or port at the bottom.*

FDA Label Image

Diagram 5 (Cefuroxime For Injection Usp And Dextrose Injectio 7)

An instructional diagram labeled 'Diagram 5' showing a medical fluid bag with a set port at the bottom. The diagram includes an arrow indicating the removal of a foil cover from the set port, likely illustrating preparation steps for intravenous use.*

FDA Label Image

3112-11 Container Label (Cefuroxime For Injection Usp And Dextrose Injectio 8)

Cefuroxime and Dextrose Injection USP 750 mg/50 mL in a Duplex container for intravenous use. The label includes instructions for reconstitution by mixing contents of both chambers, specifies the product is single-dose, sterile, nonpyrogenic, and iso-osmotic. It is labeled by B. Braun Medical Inc., Bethlehem, PA, with an NDC number 0264-3112-11. Storage and usage instructions are also detailed on the label.*

FDA Label Image

Drug Chamber Label (Cefuroxime For Injection Usp And Dextrose Injectio 9)

A drug chamber instruction panel for an intravenous drug. It provides guidance to discard the unit if the foil strip is damaged, to peel the foil strip only when ready for use, and to visually inspect the drug prior to reconstitution. It also advises consulting the package insert for complete reconstitution and administration directions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.